MedTrace Logo

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06916195 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2026-04-06

No results posted yet for this study

Summary

This observational retrospective analysis will provide useful information for clinicians and payers, and local guidelines committee members, to improve the understanding of Cytomegalovirus clinical and economic burden and clinical management of pediatric patients undergoing allogeneic Hematopoietic Stem Cells Transplantation in Italy.

Conditions

  • Cytomegalovirus Infection
  • Hematopoietic Stem Cells Transplantation

Sponsors & Collaborators

  • MSD Italia S.r.l.

    lead INDUSTRY

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-09
Primary Completion
2026-04-30
Completion
2026-07-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06916195 on ClinicalTrials.gov